Sonire Therapeutics
Shinjuku
About Sonire Therapeutics
SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU) therapy system that will employ acoustic engineering (ultrasound) technologies developed through cutting-edge academic research. SONIRE has been working on a next-generation high-intensity focused ultrasound (HIFU) treatment system as a novel therapeutic modality with the goal of giving cancer patients and their families a new future.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $21.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Nov 2022)
- Website: sonire-therapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Wellness
Social Profiles
Canonical: https://fsome.com/organization/sonire-therapeutics-78830 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.